HANSOH PHARMA: GRANT OF RESTRICTED SHARE UNITS UNDERTHE POST-IPO RSU SCHEME
HANSOH PHARMA: GRANT OF RESTRICTED SHARE UNITSUNDER THE POST-IPO RSU SCHEME
Hansoh Pharmaceutical Group: COMPLETION OF THE ISSUE OF US$600 MILLION ZEROCOUPON CONVERTIBLE BONDS DUE 2026
Hansoh Pharmaceutical Group: PROPOSED ISSUE OF US$600 MILLION ZEROCOUPON CONVERTIBLE BONDS DUE 2026
Hansoh Pharmaceutical Group: PLACING OF NEW SHARES UNDER GENERAL MANDATE ON FULLY UNDERWRITTEN BASIS
Hansoh Pharmaceutical Group: GREEN APPLICATION FORM
Hansoh Pharmaceutical Group: YELLOW APPLICATION FORM
Hansoh Pharmaceutical Group: WHITE APPLICATION FORM
Hansoh Pharmaceutical Group: GLOBAL OFFERING
Unlock the Full List